David Rodman
CMO
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | $533,000 | $2,204,704 |
| 2024 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | $520,000 | $2,877,749 |
| 2023 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | $500,000 | $2,334,207 |
| 2022 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | $411,458 | $1,106,507 |
Earnings-call appearances
-
Mineralys Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-10
Mineralys Therapeutics, Inc. (MLYS)
-
Mineralys Therapeutics, Inc. Q4 FY2024 Earnings Call2025-02-12
Mineralys Therapeutics, Inc. (MLYS)
-
Mineralys Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-12
Mineralys Therapeutics, Inc. (MLYS)
-
Mineralys Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-13
Mineralys Therapeutics, Inc. (MLYS)
-
Mineralys Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-09
Mineralys Therapeutics, Inc. (MLYS)
-
Mineralys Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-21
Mineralys Therapeutics, Inc. (MLYS)
-
Mineralys Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-07
Mineralys Therapeutics, Inc. (MLYS)
-
Mineralys Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-07
Mineralys Therapeutics, Inc. (MLYS)